Augmentin Safety in Erythromycin Allergy

Understanding Antibiotic Classes and Cross-Reactivity

The Dutch Working Party on Antibiotic Policy (SWAB) guidelines indicate that erythromycin belongs to the macrolide class of antibiotics, while Augmentin (amoxicillin/clavulanate) belongs to the beta-lactam class of antibiotics, with no cross-reactivity between them 1, 2

According to the Dutch Working Party on Antibiotic Policy (SWAB) guidelines, cross-reactivity between unrelated antibiotic classes like macrolides (erythromycin) and beta-lactams (Augmentin) is not a clinical concern 1, 3
The SWAB guidelines specifically address non-beta-lactam antibiotics (NBLAs) separately from beta-lactams, indicating they are distinct groups with different allergic profiles 2

The American Heart Association recommends confirming the nature of the previous erythromycin reaction, determining if it was a true allergic reaction or a side effect, and documenting the severity and timing of the reaction 1, 2
The American College of Cardiology suggests assessing the risk level, with low risk being non-severe reactions to erythromycin, allowing for safe use of Augmentin, and high risk being severe reactions, where Augmentin remains safe due to its unrelated antibiotic class 1, 2, 3

For patients allergic to both macrolides and penicillins, the American Academy of Dermatology recommends considering alternative antibiotics such as cephalosporins, clindamycin, fluoroquinolones, or tetracyclines based on the infection being treated 4, 5, 6

The Journal of the American Academy of Dermatology advises against confusing side effects of erythromycin with true allergic reactions, assuming cross-reactivity between unrelated antibiotic classes, withholding effective antibiotics like Augmentin unnecessarily, and failing to document the specific nature of the erythromycin allergy 1, 2, 6